These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17478886)

  • 21. Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson's disease model.
    Yan J; Yang Z; Zhao N; Li Z; Cao X
    BMC Neurosci; 2019 Jun; 20(1):31. PubMed ID: 31208386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Caenorhabditis elegans dopaminergic system: opportunities for insights into dopamine transport and neurodegeneration.
    Nass R; Blakely RD
    Annu Rev Pharmacol Toxicol; 2003; 43():521-44. PubMed ID: 12415122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sir-2.1 modulates 'calorie-restriction-mediated' prevention of neurodegeneration in Caenorhabditis elegans: implications for Parkinson's disease.
    Jadiya P; Chatterjee M; Sammi SR; Kaur S; Palit G; Nazir A
    Biochem Biophys Res Commun; 2011 Sep; 413(2):306-10. PubMed ID: 21889494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lithium fails to protect dopaminergic neurons in the 6-OHDA model of Parkinson's disease.
    Yong Y; Ding H; Fan Z; Luo J; Ke ZJ
    Neurochem Res; 2011 Mar; 36(3):367-74. PubMed ID: 21203835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.
    Kim HD; Jeong KH; Jung UJ; Kim SR
    J Med Food; 2016 Apr; 19(4):374-82. PubMed ID: 26991235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subtype selective antagonism of substantia nigra pars compacta Group I metabotropic glutamate receptors protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.
    Vernon AC; Zbarsky V; Datla KP; Croucher MJ; Dexter DT
    J Neurochem; 2007 Nov; 103(3):1075-91. PubMed ID: 17714448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Stayte S; Rentsch P; Li KM; Vissel B
    PLoS One; 2015; 10(4):e0124325. PubMed ID: 25902062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is nicotine protective against Parkinson's disease? An experimental analysis.
    García-Montes JR; Boronat-García A; López-Colomé AM; Bargas J; Guerra-Crespo M; Drucker-Colín R
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):897-906. PubMed ID: 23131151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ferulic Acid Exerts Neuroprotective Effects via Autophagy Induction in
    Long T; Wu Q; Wei J; Tang Y; He YN; He CL; Chen X; Yu L; Yu CL; Law BY; Wu JM; Qin DL; Wu AG; Zhou XG
    Oxid Med Cell Longev; 2022; 2022():3723567. PubMed ID: 35242276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine D2 agonists, bromocriptine and quinpirole, increase MPP+ -induced toxicity in PC12 cells.
    Chiasson K; Daoust B; Levesque D; Martinoli MG
    Neurotox Res; 2006 Aug; 10(1):31-42. PubMed ID: 17000468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-γ-(L-glutamyl)-L-selenomethionine shows neuroprotective effects against Parkinson's disease associated with SKN-1/Nrf2 and TRXR-1 in Caenorhabditis elegans.
    Chang CH; Wei CC; Ho CT; Liao VH
    Phytomedicine; 2021 Nov; 92():153733. PubMed ID: 34537465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
    Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
    Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-linolenic acid suppresses dopaminergic neurodegeneration induced by 6-OHDA in C. elegans.
    Shashikumar S; Pradeep H; Chinnu S; Rajini PS; Rajanikant GK
    Physiol Behav; 2015 Nov; 151():563-9. PubMed ID: 26300470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Nrf2/SKN-1-dependent glutathione S-transferase π homologue GST-1 inhibits dopamine neuron degeneration in a Caenorhabditis elegans model of manganism.
    Settivari R; VanDuyn N; LeVora J; Nass R
    Neurotoxicology; 2013 Sep; 38():51-60. PubMed ID: 23721876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valproic acid ameliorates C. elegans dopaminergic neurodegeneration with implications for ERK-MAPK signaling.
    Kautu BB; Carrasquilla A; Hicks ML; Caldwell KA; Caldwell GA
    Neurosci Lett; 2013 Apr; 541():116-9. PubMed ID: 23485787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
    Liu H; Jia L; Chen X; Shi L; Xie J
    Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans.
    Nass R; Hall DH; Miller DM; Blakely RD
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3264-9. PubMed ID: 11867711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions.
    Machado-Filho JA; Correia AO; Montenegro AB; Nobre ME; Cerqueira GS; Neves KR; Naffah-Mazzacoratti Mda G; Cavalheiro EA; de Castro Brito GA; de Barros Viana GS
    Behav Brain Res; 2014 May; 264():116-25. PubMed ID: 24525422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The divalent metal transporter homologues SMF-1/2 mediate dopamine neuron sensitivity in caenorhabditis elegans models of manganism and parkinson disease.
    Settivari R; Levora J; Nass R
    J Biol Chem; 2009 Dec; 284(51):35758-68. PubMed ID: 19801673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.